You may be aware that there’s no deferral for blood donors after they receive a vaccine against COVID-19. But you might be wondering how the blood operators made this decision. Canadian Blood Services
A study conducted by researchers in the University of Toronto QUEST program, a research collaborative supported by Canadian Blood Services, looked at what can be done to reduce the number of
With an anticipated global shortage of immune globulin products, finding alternatives to IVIg can help improve availability of a drug in high demand. A recent study shows that eltrombopag, an oral
The Intramural Research Grant Program, one of the Centre for Innovation’s most responsive and impactful research funding programs, and the Kenneth J. Fyke Program, which supports health services and
Dr. Celina Montemayor-Garcia is a researcher and transfusion medicine specialist whose main interest is understanding how genomics and bioinformatics can be used to improve care for transfusion
Blood plasma-derived IVIg holds promise as a treatment for Alzheimer’s disease. A new study suggests that combining IVIg with a new drug delivery technique that helps get IVIg into the brain could